Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START

CompletedOBSERVATIONAL
Enrollment

850

Participants

Timeline

Start Date

May 15, 2015

Primary Completion Date

December 31, 2021

Study Completion Date

March 1, 2023

Conditions
Prostatic Neoplasm
Interventions
OTHER

Active surveillance

PSA testing (every 3 months, then every 6 after 30 months), clinical visit and DRE every 6 months, prostate biopsy after 1, 4 and 7 years

PROCEDURE

Radical prostatectomy

Radical prostatectomy (open, laparoscopic or robotic)

RADIATION

Radiotherapy

External radical radiotherapy or brachitherapy

PROCEDURE

Other radical treatments

High intensity focal ultrasound, cryotherapy, others

Trial Locations (1)

10126

Oncolgy Network of Piemonte and Valle d'Aosta - Turin, Turin

All Listed Sponsors
collaborator

Compagnia di San Paolo

OTHER

collaborator

A.O.U. Città della Salute e della Scienza

OTHER

lead

Rete Oncologica Piemonte, Valle d'Aosta

OTHER

NCT03348722 - Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START | Biotech Hunter | Biotech Hunter